SCHEMBL8155355

SCHEMBL8155355

CCCCC(N)C(=O)N(CC(=O)OCC)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.45
ALDH1A1 P00352 5/20 0.42
LMNA P02545 3/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALOX5 P09917 1/20 0.41
LTA4H P09960 1/20 0.40
MC4R P32245 1/20 0.40
MC5R P33032 1/20 0.40
MC3R P41968 1/20 0.40
NPC1 O15118 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8732931 1.00 PIN1 (0.45) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL6791119 0.86 MC4R (0.50) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL6791114 0.86 MC4R (0.50) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL6298201 0.81 PIN1 (0.47) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL27565891 0.81 PIN1 (0.47) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL1883119 0.81 PIN1 (0.51) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL8155357 0.79 CTSL (0.56)
SCHEMBL5941081 0.79 PIN1 (0.56) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL25404698 0.79 PTGES (0.47) PIN1ALDH1A1LMNAHSD17B10POLB
SCHEMBL8123534 0.79 MEN1 (0.43) PIN1ALDH1A1LMNAHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030946-A FUNCTIONS REVERSIBLY, RESULTING IN TIGHT BINDING (LOW DISSOCIATION CONSTANTS) BETWEEN INHIBITOR AND TARGET ENZYME; USED TO TREAT VARIETY OF DISEAES, INCLUDING ARTHRITIS, MUSCULAR DYSTROPHY, INFLAMMATION, TUMOR INVASION, MALERIA AXYS PHARMACEUTICALS, INC. (US) 2000-02-29 US disclosed
EP-0832099-A1 REVERSIBLE CYSTEINE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1998-04-01 EP disclosed
WO-1996040737-A1 REVERSIBLE CYSTEINE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1996-12-19 WO disclosed